Revivo Therapeutics Email Format
Biotechnology ResearchNorth Carolina, United States2-10 Employees
Revivo Therapeutics is a biotechnology research company focused on developing a new class of cognitive-enhancing small molecules aimed at addressing cognitive decline. Its lead candidate, RIV-5061, targets treatment for Mild Cognitive Impairment, with ongoing work to advance into Phase 1/1b clinical testing. Based in Durham, North Carolina, the company operates as a small-scale biopharma entity and is positioned within the early-stage clinical development segment of the biotechnology industry. The organization appears to be actively pursuing development activities in cognitive health, aligning with a focus on therapeutic solutions for cognitive impairment in adults.